IONQ vs. QNT – Why Morgan Stanley Named Quantinuum Its ‘Top Quantum Play’
Morgan Stanley upgraded Quantinuum (QNT) to Buy with a $62 price target, implying 87.7% upside, while maintaining a Hold rating on IonQ (IONQ) with a $43 target, implying 36.9% upside. QNT rose 3.2% and IONQ fell 2.6% in premarket trading. Moore prefers QNT for its technological progress and execution, forecasting $2B revenue by 2030 vs. $1.8B for IONQ.
How this was made
The 30-second read
Why it matters
The rating upgrade and target revisions immediately moved both stocks, highlighting the influence of analyst opinions in niche tech sectors.
Market read
Analyst rating changes in the emerging quantum computing space can trigger swift price reactions, offering short‑term trading opportunities.
What to watch
Potential supply‑chain constraints for hardware and regulatory funding risks are not addressed.
Background
Morgan Stanley released a fresh analyst report comparing Quantinuum and IonQ, assigning a top‑play rating to Quantinuum.
Ticker impact
Morgan Stanley upgraded Quantinuum to Buy, cut price target to $62 and the stock rose 3.2% premarket.
likely upward pressure as investors price in the buy rating and revised target
Analyst rating change is fresh and directly moved the share price.
Morgan Stanley kept Hold on IonQ, cut price target to $43 and the stock fell 2.6% premarket.
likely downside pressure as the downgrade target reduces expectations
Analyst downgrade is new information and already moved the share price.
Market effects
Quantum computing sector may see heightened investor interest in error‑correction advances.
US quantum‑computing stocks experienced immediate price moves.
Developments could influence global tech investors tracking quantum hardware progress.
Counterpoint
Some investors may view the target cuts as a sign of over‑optimism and could short on the upside.
Key entities
- analyst_firmMorgan Stanley
Provided the upgrade and price target revisions.
- companyQuantinuum
Received a Buy rating and target cut to $62.
- companyIonQ
Maintained Hold rating with target cut to $43.


